// App-Quantinova.ai

359 : Attainment of Remission with Anifrolumab: A Post Hoc Analysis of Pooled TULIP-1 and TULIP-2 Datasets

Researchers

Presenter

  • Ronald Van Vollenhoven

Principal Investigators

  • Eric F. Morand

  • Richard A. Furie

  • Ian N. Bruce

  • Gabriel Abreu

  • Raj Tummala

  • Hussein Al-Mossawi

  • Catharina Lindholm

Medical Centers

  • Deakin University, Melbourne, Australia

  • Northwell Health, Great Neck, NY

  • University of Manchester, Manchester, United Kingdom

  • AstraZeneca, Molndal, Sweden

  • AstraZeneca, Gaithersburg, MD

  • Astra Zeneca, Cambridge, United Kingdom

  • AstraZeneca, Gothenburg, Sweden

Locations

  • Netherlands

  • Australia

  • United States

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • MDX1333

  • Prednisone

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • III

Study Id's

  • NCT02446912

  • NCT02446899

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved